ストックスクリーナーアプリを入手
2.705
0.37%
0.015
前日終値:
$2.69
開ける：
$2.74
24時間の取引高:
383.44K
Relative Volume:
0.37
時価総額：
$127.19M
収益：
$138.90M
当期純損益:
$-107.15M
株価収益率:
-1.0721
EPS:
-2.5232
ネットキャッシュフロー:
$-79.85M
1週間 パフォーマンス:
+7.57%
1か月 パフォーマンス:
-17.68%
6か月 パフォーマンス:
-63.41%
1年 パフォーマンス:
-44.33%
1日の値動き範囲:
$2.70
$2.82
1週間の範囲:
$2.425
$2.82
52週間の値動き範囲:
$2.395
$8.77
Quanterix Corp Stock (QTRX) Company Profile
Compare QTRX vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
QTRX
Quanterix Corp
|
2.70 | 126.72M | 138.90M | -107.15M | -79.85M | -2.5232 |
ABT
Abbott Laboratories
|
86.69 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
311.94 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.72 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.52 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.33 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Quanterix Corp Stock (QTRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-11 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2024-02-01 | 開始されました | Scotiabank | Sector Outperform |
| 2023-09-25 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2023-08-08 | アップグレード | SVB Securities | Market Perform → Outperform |
| 2023-05-23 | アップグレード | Goldman | Neutral → Buy |
| 2022-08-15 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2022-08-09 | ダウングレード | Cowen | Outperform → Market Perform |
| 2022-08-09 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-03-02 | アップグレード | Goldman | Sell → Neutral |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-06-04 | 開始されました | Goldman | Sell |
すべてを表示
Quanterix Corp (QTRX) 最新ニュース
Quanterix targets $169M-$174M 2026 revenue while preparing HD-X IVD filing in 2027 - MSN
Quanterix (QTRX) CFO reports RSU vesting and tax-withholding share dispositions - Stock Titan
Quanterix (QTRX) CTO gains 1,558 shares from RSU vesting, 467 withheld for tax - Stock Titan
Quanterix Corp stock (US74876Y1001): Analyst price target raised while shares trade near lows - AD HOC NEWS
Portolan Capital, George McCabe report 6.25% stake in Quanterix (QTRX) - Stock Titan
Quanterix (NASDAQ: QTRX) — Ameriprise reports 3,542,374 shared votes - Stock Titan
QTRX Technical Analysis | Trend, Signals & Chart Patterns | QUANTERIX CORP (NASDAQ:QTRX) - ChartMill
Quanterix stock (US74876Y1001): Biotech diagnostics firm faces headwinds amid guidance revision - AD HOC NEWS
AMERIPRISE FINANCIAL INC Significantly Reduces Stake in Quanteri - GuruFocus
Quanterix (QTRX) Announces CFO Departure and Transition Plans - GuruFocus
Quanterix CFO Vandana Sriram to depart in June - Investing.com
Quanterix CFO Michael J. Doyle to Depart on July 3, 2026; Search for Successor Begins - geneonline.com
Quanterix (QTRX) CFO Vandana Sriram to depart in June 2026 after planned transition - Stock Titan
Quanterix finance chief to depart after June 15 handover - Stock Titan
TradingKey - TradingKey
MSN Money - MSN
Quanterix (NASDAQ:QTRX) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Quanterix Corporation 2026 Q1 Financials: Akoya Acquisition, Revenue Performance & Forward-Looking Statements - Minichart
QTRX Maintained by TD Cowen -- Price Target Lowered to $4.00 - GuruFocus
Q1 2026 Quanterix Corp Earnings Call Transcript - GuruFocus
Earnings call transcript: Quanterix Q1 2026 EPS beats, revenue misses By Investing.com - Investing.com India
Quanterix CEO Everett Cunningham Highlights Market Leadership in Earnings Call - HarianBasis.co
Ameriprise Financial (NASDAQ: QTRX) reports 990,224 shares, 2.1% stake - Stock Titan
Quanterix Q1 Earnings Call Highlights - Yahoo Finance
Quanterix Q1 2026 slides: $85M synergies offset organic decline - Investing.com
Quanterix Corporation (QTRX) Reports Q1 Loss, Lags Revenue Estimates - Yahoo! Finance Canada
Earnings call transcript: Quanterix Q1 2026 EPS beats, revenue misses - Investing.com
Quanterix (NASDAQ:QTRX) Beats Q1 2026 EPS Estimates Despite Revenue Miss - ChartMill
Quanterix (NASDAQ: QTRX) grows revenue 20% but books $19.3M impairment - Stock Titan
QUANTERIX ($QTRX) Releases Q1 2026 Earnings, Stock Rises - Quiver Quantitative
Quanterix (NASDAQ: QTRX) grows Q1 revenue 20% and keeps 2026 outlook - Stock Titan
Quanterix keeps 2026 outlook, eyes FDA decision on Alzheimer’s test - Stock Titan
Quanterix partners with Tempus AI on Alzheimer’s blood test - Investing.com
Quanterix Corp expected to post a loss of 54 cents a shareEarnings Preview - TradingView
How The Quanterix (QTRX) Story Is Shifting After The Latest Fair Value Reset - Yahoo Finance
Quanterix (QTRX) COO logs RSU conversion and small tax share disposal - Stock Titan
Quanterix rises on CMS price for LucentAD Alzheimer blood biomarker test - MSN
Quanterix (QTRX) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Quanterix (QTRX) price target decreased by 13.33% to 6.63 - MSN
Quanterix schedules after-close Q1 results, 4:30 p.m. ET call - Stock Titan
[ARS] Quanterix Corp SEC Filing - Stock Titan
Quanterix (NASDAQ: QTRX) details 2026 virtual meeting and pay votes - Stock Titan
Quanterix Corp (QTRX) 財務データ
収益
当期純利益
現金流量
EPS
Quanterix Corp (QTRX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| WALT DAVID R | Director |
Jun 13 '25 |
Buy |
6.14 |
123,990 |
760,803 |
1,866,933 |
| WALT DAVID R | Director |
Jun 12 '25 |
Buy |
6.23 |
36,010 |
224,166 |
1,742,943 |
| Toloue Masoud | President & CEO |
Jun 09 '25 |
Buy |
5.42 |
45,900 |
248,723 |
518,922 |
| WALT DAVID R | Director |
Jun 06 '25 |
Buy |
5.43 |
131,869 |
716,576 |
1,628,802 |
| WALT DAVID R | Director |
Jun 09 '25 |
Buy |
5.34 |
78,131 |
417,220 |
1,706,933 |
| DONNELLY WILLIAM P | Director |
Jun 06 '25 |
Buy |
5.44 |
93,113 |
506,348 |
139,094 |
0.32%
0.17%
大文字化:
|
ボリューム (24 時間):